BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31655066)

  • 1. Intrauterine fluid instillation to confirm tubal occlusion after transcervical permanent contraception: A pilot study
    Patil E; Thurmond A; Hart K; Seguin J; Edelman A; Jensen JT
    Contraception; 2020 Jan; 101(1):40-45. PubMed ID: 31655066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure dynamics in the non-gravid uterus: intrauterine pressure cannot confirm tubal occlusion after non-surgical permanent contraception.
    Patil E; Thurmond A; Edelman A; Fu R; Lambert W; Seguin J; Jensen JT
    Contraception; 2017 Nov; 96(5):330-335. PubMed ID: 28687179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).
    Thiel J; Rattray D; Cher DJ
    J Minim Invasive Gynecol; 2014; 21(6):1055-60. PubMed ID: 24861649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-step transvaginal three-dimensional hysterosalpingo-foam sonography (3D-HyFoSy) confirmation test for Essure® follow-up: a multicenter study.
    Zizolfi B; Lazzeri L; Franchini M; Di Spiezio Sardo A; Nappi C; Piccione E; Exacoustos C
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):134-141. PubMed ID: 28067009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essure insert expulsion after 3-month hysterosalpingogram confirmation of bilateral tubal occlusion and bilateral correct placement: case report.
    Garcia AL; Lewis RM; Sloan AL
    J Minim Invasive Gynecol; 2013; 20(1):107-11. PubMed ID: 23312251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tubal occlusion after transcervical polidocanol foam (PF) infusion in baboons.
    Jensen JT; Hanna C; Yao S; Bauer C; Morgan TK; Slayden OD
    Contraception; 2015 Aug; 92(2):96-102. PubMed ID: 26070857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history and current status of fallopian tube pressures - developing alternate methods for confirmation of tubal occlusion.
    Patil E; Thurmond A
    Contraception; 2015 Aug; 92(2):124-7. PubMed ID: 25592081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal Tubal Patency Demonstrated Through Air Infusion During Flexible Office Hysteroscopy Is Predictive of Whole Tubal Patency.
    Parry JP; Riche D; Aldred J; Isaacs J; Lutz E; Butler V; Shwayder J
    J Minim Invasive Gynecol; 2017; 24(4):646-652. PubMed ID: 28216455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study.
    Chudnoff SG; Nichols JE; Levie M
    J Minim Invasive Gynecol; 2015; 22(6):951-60. PubMed ID: 25917278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of repeated transcervical quinacrine pellet insertions for female sterilization.
    el Kady AA; Nagib HS; Kessel E
    Fertil Steril; 1993 Feb; 59(2):301-4. PubMed ID: 8425622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Hysterosalpingo-Foam Sonography for Assessment of the Efficacy of Essure Hysteroscopic Sterilization.
    Rosič M; Žegura B; Vadnjal Đonlagić S
    J Ultrasound Med; 2018 Aug; 37(8):1929-1935. PubMed ID: 29344973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of tubal patency following transcervical administration of polidocanol foam: initial studies in rhesus macaques.
    Jensen JT; Hanna C; Yao S; Micks E; Edelman A; Holden L; Slayden OD
    Contraception; 2014 Jun; 89(6):540-9. PubMed ID: 24560476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essure transcervical tubal sterilization: a 5-year x-ray follow up.
    Franchini M; Boeri C; Calzolari S; Imperatore A; Cianferoni L; Litta P; Giarrè G; Zerbetto I; Moncini I; Florio P
    Fertil Steril; 2011 May; 95(6):2114-5. PubMed ID: 21392751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of hysterosalpingo-foam-sonography to confirm tubal occlusion after Essure® placement as treatment for hydrosalpinges.
    Dreyer K; Hompes PG; Mijatovic V
    Reprod Biomed Online; 2015 Apr; 30(4):421-5. PubMed ID: 25682307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysteroscopic sterilization in patients with a Mirena intrauterine device: transition from extended interval to permanent contraception.
    Tatalovich JM; Anderson TL
    J Minim Invasive Gynecol; 2010; 17(2):228-31. PubMed ID: 20226413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast infusion sonography in the post-Essure setting.
    Connor V
    J Minim Invasive Gynecol; 2008; 15(1):56-61. PubMed ID: 18262145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
    Karthigasu KA; Garry R; Hart R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):365-7. PubMed ID: 16866803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubal perforation by Essure: three different clinical presentations.
    Langenveld J; Veersema S; Bongers MY; Koks CA
    Fertil Steril; 2008 Nov; 90(5):2011.e5-10. PubMed ID: 18692813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant relationship between Essure microinsert position and tubal occlusion.
    Hou MY
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27466315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Case report of failed tubal occlusion using Essure pbc (permanent birth control) hysteroscopic sterilisation procedure.
    Valle RF
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):155-6. PubMed ID: 17355311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.